FIELD: medicine.
SUBSTANCE: invention refers to a pharmaceutical composition with anti-ischemic and antioxidant activity in the form of tablets or capsules, and a method for preparing it. The composition contains 4-((3-oxo-3-ethoxypropanoyl)amino)benzoic acid in an amount of 40 to 80 wt %, an amino-containing compound and pharmaceutically acceptable excipients. The amino-containing compound is specified in a group of trometamol, methyl glucamine and L-lysine; 1 mole of 4-((3-oxo-3-ethoxypropanoyl)amino)benzoic acid is accounted for 0.05 to 0.25 mole of the above amino-containing compound. The composition also contains lactose, microcrystalline cellulose, calcium stearate and other pharmaceutically acceptable excipients. According to the method for preparing the composition, taking 4-((3-oxo-3-ethoxypropanoyl)amino)benzoic acid and amino-containing compound in molar ratio 1:0.05 to 1:0.25, pre-mixing, moisturising with a aqueous or alcohol solution of a binding agent, adding pharmaceutically acceptable excipients in such an amount to provide the content of 4-((3-oxo-3-ethoxypropanoyl)amino)benzoic acid from 40 to 80 wt %, granulating the mixture, drying and producing tablets or capsules according to the known technique.
EFFECT: implementing the above application.
6 cl, 7 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING WATER-SOLUBLE LYOPHILISATE OF 4-(3-OXO-3-ETHOXYPROPANOYL)AMINO)BENZOIC ACID POSSESSING ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY | 2015 |
|
RU2602665C1 |
PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
PHARMACEUTICAL COMPOSITION WITH ANTI-THERAPEUTIC ACTIVITY AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2624857C1 |
PHARMACEUTICAL COMPOSITION ELICITING HEPATOPROTECTIVE EFFECT AND MEDICINAL AGENT | 2003 |
|
RU2257208C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY, CARDIO- AND CHONDROPROTECTIVE ACTIVITY, ACTION PREVENTING GASTROPATHIES CAUSED BY NSAID, AND METHOD FOR PREPARING IT | 2011 |
|
RU2502507C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING HIV INFECTION, METHOD FOR PREPARING IT, AND METHOD OF TREATING | 2012 |
|
RU2505286C1 |
PHARMACEUTICAL COMPOSITION ELICITING NOOTROPIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240783C1 |
PHARMACEUTICAL COMPOSITION ON THE BASIS OF FUCOIDAN FOR ORAL USE AND METHOD OF ITS PRODUCTION | 2017 |
|
RU2657615C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTI-ANGINAL, ANTI-ISCHEMIC AND NOOTROPIC EFFECT | 2003 |
|
RU2225713C1 |
Authors
Dates
2015-04-10—Published
2013-12-03—Filed